Management reaffirmed their guidance of 70%-75% revenue growth for 2025, emphasizing a back-loaded trajectory as the TULSA+ program and AI module gain traction. Arun Menawat noted that the CAPTAIN ...

April's clearances included respiratory disease assays, a Gram-negative infection test, and assays to aid the diagnosis and monitoring of thyroid disease.